Cambridge Heart, Inc. (OTCBB:CAMH), today announced results from the ALPHA (T-Wave Alternans in Patients With Heart Failure) clinical study will be featured as a late-breaker presentation during the 56th Annual Scientific Session of The American College of Cardiology being held March 24 – 27 in New Orleans. The presentation will be given at 8:30 AM CDT during a plenary session on Sunday, March 25, 2007.
